Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis

MLA

C. Meurot, et al. “Liraglutide, a Glucagon-like Peptide 1 Receptor Agonist, Exerts Analgesic, Anti-Inflammatory and Anti-Degradative Actions in Osteoarthritis.” Scientific Reports, vol. 12, no. 1, Jan. 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1038/s41598-022-05323-7.

APA

C. Meurot, C. Martin, L. Sudre, J. Breton, C. Bougault, R. Rattenbach, K. Bismuth, C. Jacques, & F. Berenbaum. (2022). Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis. Scientific Reports, 12(1), 1–15. https://doi.org/10.1038/s41598-022-05323-7

Chicago

C. Meurot, C. Martin, L. Sudre, J. Breton, C. Bougault, R. Rattenbach, K. Bismuth, C. Jacques, and F. Berenbaum. 2022. “Liraglutide, a Glucagon-like Peptide 1 Receptor Agonist, Exerts Analgesic, Anti-Inflammatory and Anti-Degradative Actions in Osteoarthritis.” Scientific Reports 12 (1): 1–15. doi:10.1038/s41598-022-05323-7.